MoneyWorks4Me

The turnover zoomed to Rs. 41450.00 millions, up 50.07% for the September 2026 quarter as against Rs. 27620.00 millions during the year-ago period.A slender decline of -16.58% was recorded to Rs. 4980.00  millions from Rs. 5970.00 millions in the corresponding previous quarter.Operating profit for the quarter ended September 2026 rose to 15600.00 millions as compared to 10450.00 millions of corresponding quarter ended September 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 41450.00 27620.00 50.07 83030.00 53780.00 54.39 107120.00 96820.00 10.64
Other Income -110.00 -270.00 -59.26 -320.00 -320.00 0.00 180.00 320.00 -43.75
PBIDT 15600.00 10450.00 49.28 31120.00 20190.00 54.14 40720.00 36070.00 12.89
Interest 2870.00 370.00 675.68 5800.00 820.00 607.32 3410.00 2130.00 60.09
PBDT 12630.00 9950.00 26.93 25010.00 19240.00 29.99 36610.00 33700.00 8.64
Depreciation 5870.00 1890.00 210.58 11620.00 3760.00 209.04 7640.00 7600.00 0.53
PBT 6760.00 8060.00 -16.13 13390.00 15480.00 -13.50 28970.00 26100.00 11.00
TAX 1780.00 2090.00 -14.83 3490.00 4000.00 -12.75 7050.00 7220.00 -2.35
Deferred Tax -820.00 -110.00 645.45 -1770.00 -180.00 883.33 -150.00 1810.00 -108.29
PAT 4980.00 5970.00 -16.58 9900.00 11480.00 -13.76 21920.00 18880.00 16.10
Equity 1901.80 1692.30 12.38 1901.80 1692.30 12.38 1692.30 1692.30 0.00
PBIDTM(%) 37.64 37.83 -0.53 37.48 37.54 -0.16 38.01 37.25 2.04
Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1303.00
Cipla 1353.00
Lupin 1950.00
Zydus Lifesciences 1158.10
View more..